RXI PHARMACEUTICALS CORP NEW's ticker is RXII and the CUSIP is 74979C303. A total of 26 filers reported holding RXI PHARMACEUTICALS CORP NEW in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $257,000 | -13.8% | 950,900 | +22.1% | 0.00% | -100.0% |
| Q4 2015 | $298,000 | +38.6% | 778,800 | +34.3% | 0.00% | 0.0% |
| Q3 2015 | $215,000 | -13.3% | 580,000 | +14.4% | 0.00% | 0.0% |
| Q2 2015 | $248,000 | +1553.3% | 507,000 | +2291.5% | 0.00% | – |
| Q1 2015 | $15,000 | – | 21,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 6,126,482 | $3,002,000 | 0.16% |
| Bison Wealth, LLC | 25,710 | $13,000 | 0.01% |
| Renaissance Technologies | 507,000 | $248,000 | 0.00% |
| Virtu KCG Holdings LLC | 99,203 | $49,000 | 0.00% |
| AMERICAN INTERNATIONAL GROUP, INC. | 1,136 | $557,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 6,000 | $3,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 1,005 | $0 | 0.00% |
| NORTHERN TRUST CORP | 12,782 | $6,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 266,380 | $130,000 | 0.00% |
| Pine River Capital Management L.P. | 145,000 | $0 | 0.00% |